CNR1 and central nervous system cancer: To corroborate these findings we then conducted western blot analysis after 24 h treatment with SR141716 on 2 primary glioma cell lines characterized by the highest CB1 expression (GBM17, GBM18) and on 2 low- CB1-expressing cell lines (GBM25, GBM27).